Michaelangelo94: That's not the question FDA asked. They know the panelists are not fortune tellers. They asked if there was evidence that Vascepa and Statins have an effect in reducing
CVD. The answer is a definitive yes. As to the REDUC-IT results, that is the reason for PH IV
Post Marketing trial is being run. If you re read the question, the answer to your hypothesis is
If you are still long amarin as i am, selling now will assure you a financial loss.
to my way of thinking, "the data is the data" and the two questions are both reasonable
and answerable. Should someone sell now, not only will he suatain a loss, but if the drug is approved 10-16-13, you will feel intolerably stupid as well.
one man's opinion.